Patents by Inventor Meghan E. Norvell

Meghan E. Norvell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11603400
    Abstract: The present invention generally relates to methods of generating antibodies against a species of pathogen that involve identifying the pathogen that is most genetically representative of member of pathogen species and using the identified pathogen to generate an antibody.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: March 14, 2023
    Assignee: DNAE Group Holdings Limited
    Inventors: Colin Dykes, Sergey A. Dryga, Lisa-Jo Ann Clarizia, Eddie W. Adams, Meghan E. Norvell
  • Patent number: 10379113
    Abstract: The invention generally relates to methods for indicating whether an assay for isolating targets is properly isolating and detecting targets. Methods of the invention involve obtaining a sample suspected of a containing target, introducing a detectable marker into the sample, conducting an assay using magnet particles to isolate the detectable marker and the target if it is present in the sample, determining the presence or absence of the target; and confirming that the assay functioned properly by determining presence or absence of the detectable marker.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: August 13, 2019
    Assignee: DNAE Group Holdings Limited
    Inventor: Meghan E. Norvell
  • Publication number: 20170131270
    Abstract: The invention generally relates to methods for indicating whether an assay for isolating targets is properly isolating and detecting targets. Methods of the invention involve obtaining a sample suspected of a containing target, introducing a detectable marker into the sample, conducting an assay using magnet particles to isolate the detectable marker and the target if it is present in the sample, determining the presence or absence of the target; and confirming that the assay functioned properly by determining presence or absence of the detectable marker.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Inventor: Meghan E. Norvell